Clinical Characteristics and Outcomes of Sepsis-related Vs Non-sepsis-related ARDS
Overview
Authors
Affiliations
Background: ARDS may occur after either septic or nonseptic injuries. Sepsis is the major cause of ARDS, but little is known about the differences between sepsis-related and non-sepsis-related ARDS.
Methods: A total of 2,786 patients with ARDS-predisposing conditions were enrolled consecutively into a prospective cohort, of which 736 patients developed ARDS. We defined sepsis-related ARDS as ARDS developing in patients with sepsis and non-sepsis-related ARDS as ARDS developing after nonseptic injuries, such as trauma, aspiration, and multiple transfusions. Patients with both septic and nonseptic risks were excluded from analysis.
Results: Compared with patients with non-sepsis-related ARDS (n = 62), patients with sepsis-related ARDS (n = 524) were more likely to be women and to have diabetes, less likely to have preceding surgery, and had longer pre-ICU hospital stays and higher APACHE III (Acute Physiology and Chronic Health Evaluation III) scores (median, 78 vs 65, P < .0001). There were no differences in lung injury score, blood pH, Pao(2)/Fio(2) ratio, and Paco(2) on ARDS diagnosis. However, patients with sepsis-related ARDS had significantly lower Pao(2)/Fio(2) ratios than patients with non-sepsis-related ARDS patients on ARDS day 3 (P = .018), day 7 (P = .004), and day 14 (P = .004) (repeated-measures analysis, P = .011). Compared with patients with non-sepsis-related ARDS, those with sepsis-related had a higher 60-day mortality (38.2% vs 22.6%; P = .016), a lower successful extubation rate (53.6% vs 72.6%; P = .005), and fewer ICU-free days (P = .0001) and ventilator-free days (P = .003). In multivariate analysis, age, APACHE III score, liver cirrhosis, metastatic cancer, admission serum bilirubin and glucose levels, and treatment with activated protein C were independently associated with 60-day ARDS mortality. After adjustment, sepsis-related ARDS was no longer associated with higher 60-day mortality (hazard ratio, 1.26; 95% CI, 0.71-2.22).
Conclusion: Sepsis-related ARDS has a higher overall disease severity, poorer recovery from lung injury, lower successful extubation rate, and higher mortality than non-sepsis-related ARDS. Worse clinical outcomes in sepsis-related ARDS appear to be driven by disease severity and comorbidities.
Bunger V, Menk M, Hunsicker O, Krannich A, Balzer F, Spies C BMC Anesthesiol. 2025; 25(1):121.
PMID: 40082753 PMC: 11905513. DOI: 10.1186/s12871-025-02988-1.
do Nascimento M, Ferreira L, Vieira Junior J, Deheinzelin D, Aparecida Santos Nussbaum A, Toshihiro Sakamoto L Sci Rep. 2025; 15(1):5512.
PMID: 39953195 PMC: 11829037. DOI: 10.1038/s41598-025-89783-7.
Wu X, Guo Y J Inflamm Res. 2024; 17:9119-9133.
PMID: 39588141 PMC: 11586271. DOI: 10.2147/JIR.S488463.
Subphenotypic features of patients with sepsis and ARDS: a multicenter cohort study.
Li N, Fang D, Ge F, Zhang L, Liu Y, Jin H Front Med (Lausanne). 2024; 11:1476512.
PMID: 39554506 PMC: 11563817. DOI: 10.3389/fmed.2024.1476512.
Precision Medicine in Acute Respiratory Distress Syndrome: Progress, Challenges, and the Road ahead.
Leonard J, Sinha P Clin Chest Med. 2024; 45(4):835-848.
PMID: 39443001 PMC: 11507056. DOI: 10.1016/j.ccm.2024.08.005.